Skip to content
value.today
Beyond Air, Inc. logo

Beyond Air, Inc.

XAIR
$4 Mmarket cap on Oct 30, 2026-93.2% since Jan 2024
Compare
World rank
#27,230
Revenue
$8 M
For year ending March-2026
Net income
$-33 M
-432.9% margin
SEC filing
Employees
54
As of March 31, 2026
SEC filing

Beyond Air, Inc. in brief

Beyond Air, Inc. is a listed company in the Medical Equipment industry, based in Garden City, New York, USA. Its market value was $4 M on 30 October 2026, which makes it the 27,230th largest listed company in the world and the 4,439th largest in the USA on this site. In the year to March 2026 it had sales of $8 M and a net loss of $33 M. It employs about 54 people and Robert Scott Goodman is its chief executive. Its shares trade under the symbol XAIR (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Beyond Air, Inc.

We are a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide generators and delivery systems capable of generating NO from ambient air. The Company’s first device, LungFit® PH received premarket approval from the FDA in June 2022. The NO generated by the LungFit® PH system is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. This condition is commonly referred to as persistent pulmonary hypertension of the newborn. The LungFit® platform can generate NO up to 400 parts per million for delivery to a patient’s lungs directly or via a ventilator. LungFit® can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. In July 2022, we commenced marketing LungFit® PH in the United States for PPHN as a medical device.

From the company's annual report filed with the US SEC: read the report

Beyond Air, Inc. timeline

3 events, 2015–2019
  1. 2015
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2016
  4. ✎
    Renamed AIT Therapeutics, Inc.
    Formerly KokiCare, Inc..
  5. 2019
  6. ✎
    Renamed Beyond Air, Inc.
    Formerly AIT Therapeutics, Inc..

Events of Beyond Air, Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$61 M$123 M$184 M$245 M2020202120222023202420252026

World rank over time

▼ down 7,191 places since 2020
2020-01-01: #20045#20,04520202021-01-01: #18553#18,55320212022-01-07: #18209#18,20920222022-12-25: #18396#18,39620222023-07-30: #21150#21,15020232024-01-05: #24226#24,22620242026-03-08: #12816#12,81620262026-08-01: #23448#23,44820262026-10-14: #27256#27,25620262026-10-30: #27236#27,2362026

Rank in USA: #3,877 (Jan 2020) · #3,742 (Jan 2021) · #3,726 (Jan 2022) · #3,750 (Dec 2022) · #4,137 (Jul 2023) · #3,996 (Jan 2024) · #2,390 (Mar 2026) · #4,099 (Aug 2026) · #4,388 (Oct 2026) · #4,439 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
0.5×
Price / book
0.6×
Free cash flow yield
-485.1%
Net margin (TTM)
-407.6%
Operating margin
-378.1%
Return on equity
-544.5%
Liabilities / assets
82.5%
Net debt
$6M
Revenue growth
+107.6%
R&D / revenue
133.3%
Revenue per employee
$142 K
Profit per employee
$-616 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Mar 2019: revenue $8M, net income $-7M$8MFY19Fiscal year ending Mar 2020: revenue $1M, net income $-20M$1MFY20Fiscal year ending Mar 2021: revenue $1M, net income $-23M$1MFY21Fiscal year ending Mar 2022: revenue —, net income $-43M—FY22Fiscal year ending Mar 2023: revenue —, net income $-56M—FY23Fiscal year ending Mar 2024: revenue $1M, net income $-60M$1MFY24Fiscal year ending Mar 2025: revenue $4M, net income $-47M$4MFY25Fiscal year ending Mar 2026: revenue $8M, net income $-33M$8MFY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Mar 2026$8M+107.6%$-29M$-33M-432.9%
Mar 2025$4M+219.0%$-45M$-47M-1260.0%
Mar 2024$1M—$-63M$-60M-5193.1%
Mar 2023——$-52M$-56M—
Mar 2022——$-41M$-43M—
Mar 2021$1M-37.4%$-22M$-23M-2629.9%
Mar 2020$1M-82.0%$-18M$-20M-1434.5%
Mar 2019$8M—$-3M$-7M-85.0%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Mar 2026$-18M$1M$-19M$-4.01—
Mar 2025$-38M$6M$-44M$-13.77—
Mar 2024$-56M$6M$-62M$-1.82—
Mar 2023$-33M$4M$-37M$-1.86—
Mar 2022$-23M$1M$-25M——
Mar 2021$-20M$1M$-21M$-1.27—
Mar 2020$-15M$0M$-15M$-1.78—
Mar 2019$1M$0M$1M$-0.77—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$8M
Net income, trailing 12 months
$-33M
RevenueNet income
Three months to Dec 2024: revenue $1M, net income $-13M$1MDec ’24Three months to Mar 2025 (from the annual report): revenue $1M, net income $-8M$1MMar ’25Three months to Jun 2025: revenue $2M, net income $-8M$2MJun ’25Three months to Sep 2025: revenue $2M, net income $-8M$2MSep ’25Three months to Dec 2025: revenue $2M, net income $-7M$2MDec ’25Three months to Mar 2026 (from the annual report): revenue $2M, net income $-10M$2MMar ’26Three months to Jun 2026: revenue $2M, net income $-8M$2MJun ’26Three months to Sep 2026: revenue $2M, net income $-8M$2MSep ’26

Latest quarter to Sep 2026: revenue $2M (+27.5% on a year earlier), net income $-8M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Beyond Air, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$8 M
Operating income
$-29 M
Net income
$-33 M

For year ending March-2026 · source: SEC filing

Balance sheet

Total assets
$35 M
Total liabilities
$29 M
Total equity
$6 M

As of March-2026

Top 23 institutional investors in Beyond Air, Inc.#

As of Sep 30, 2026
23 institutions held 218,607 shares (about 13.1% of the shares outstanding) on Sep 30, 2026. The ten largest hold 13.0%. Source: SEC Form 13F filings, filed through Nov 18, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 23 largest institutional investors in Beyond Air, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Armistice Capital, LLC103,000New6.18%$0 MNov 16, 2026
2Balyasny Asset Management L.P.71,206New4.27%$0 MNov 16, 2026
3Daytona Street Capital LLC17,722New1.06%$0 MOct 15, 2026
4HRT Financial LP12,672New0.76%$0 MNov 13, 2026
5Bleichroeder LP4,325New0.26%$0 MNov 13, 2026
6Vanguard Capital Management LLC3,138New0.19%$0 MNov 13, 2026
7Vanguard Fiduciary Trust Co1,468New0.09%$0 MNov 13, 2026
8UBS Group AG1,281New0.08%$0 MNov 10, 2026
9Tower Research Capital LLC (TRC)1,238New0.07%$0 MNov 16, 2026
10Jones Financial Companies Lllp1,000New0.06%$0 MNov 13, 2026
11BlackRock, Inc.933New0.06%$0 MNov 13, 2026
12Osaic Holdings, Inc.403New0.02%$0 MNov 12, 2026
13PFS Partners, LLC100New0.01%$0 MOct 21, 2026
14IFP Advisors, Inc56New0.00%$0 MOct 16, 2026
15Robinhood Markets, Inc.28—0.00%$0 MNov 18, 2026
16NewEdge Advisors, LLC19New0.00%$0 MNov 13, 2026
17Group One Trading LLC5New0.00%$0 MNov 10, 2026
18BNP Paribas Financial Markets4New0.00%$0 MNov 12, 2026
19Continuum Advisory, LLC3New0.00%$0 MNov 13, 2026
20Godsey & Gibb, Inc2New0.00%$0 MOct 14, 2026
21Caitong International Asset Management Co., Ltd2New0.00%$0 MOct 29, 2026
22Jpmorgan Chase & Co1New0.00%$0 MNov 12, 2026
23Morgan Stanley1New0.00%$0 MNov 13, 2026

Mutual funds holding Beyond Air, Inc.#

5 funds hold shares worth $0 M. Since their previous reports 2 added shares and 0 sold, buying $0 M net.
Mutual funds holding Beyond Air, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC102,787$0 M—<0.01%+72%May 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.62,741$0 M—<0.01%+96%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC8,134$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC6,356$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC1,698$0 M—<0.01%no changeMay 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jun 30, 2026. The 5 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Beyond Air, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$287 K
6 purchases, 3 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$287 K
open market only
Insiders on file
16
since
$2.1 M-$59 K$0Nov 2023: bought $18 K (1 trades), sold $0 (0 trades)Nov 23Dec 2023: bought $2.1 M (2 trades), sold $59 K (3 trades)Aug 2024: bought $113 K (4 trades), sold $0 (0 trades)AugSep 2024: bought $738 K (2 trades), sold $0 (0 trades)Feb 2025: bought $2 K (1 trades), sold $0 (0 trades)FebMar 2025: bought $250 K (2 trades), sold $0 (0 trades)Jul 2025: bought $20 K (1 trades), sold $0 (0 trades)JulJul 2026: bought $225 K (2 trades), sold $0 (0 trades)Sep 2026: bought $13 K (2 trades), sold $0 (0 trades)SepOct 2026: bought $49 K (2 trades), sold $0 (0 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Beyond Air, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Yi-Chien Lin10% ownerBuy+2,607$2.210$6 K148,000Form 4
filed Yi-Chien Lin10% ownerBuy+15,393$2.800$43 K145,393Form 4
filed Yi-Chien Lin10% ownerBuy+2,000$2.710$5 K130,000Form 4
filed Yi-Chien Lin10% ownerBuy+3,000$2.690$8 K128,000Form 4
filed Robert Scott GoodmanChief Executive Officer, DirectorBuy+34,722$5.760$200 K34,822Form 4
filed Daniel J. MoorheadChief Financial OfficerBuy+4,340$5.760$25 K4,340Form 4
filed Steven A. LisiCEO and Chairman of the Board, DirectorBuy+6,000$3.250$20 K3.33 MForm 4
filed Robert CareyDirectorBuy+990,000$0.250$248 K4.07 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Beyond Air, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
75,069
12.7% of shares · 4.79 days to cover
Buybacks, Q4 2017
$0M
Q4 2017
Shares sold short, last 24 reportsAll stocks →

Stock splits: 100-for-1 split

Beyond Air, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q4 2017Q4 2017$0M
Q3 2017Q3 2017$0M
Q2 2017Q2 2017$0M
Q1 2017Q1 2017$0M

Trading halts

  • 2026-08-27 19:57 UTC, code LUDP, resumed 20:00 UTC
  • 2026-07-10 23:50 UTC, code T3, resumed 13:00 UTC
  • 2025-07-11 23:50 UTC, code T3, resumed 13:00 UTC

Fails to deliver

  • : 835 shares at $2.37
  • : 3,688 shares at $2.36
  • : 1,035 shares at $2.14
  • : 2,001 shares at $2.34
  • : 974 shares at $2.21

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Beyond Air, Inc. scorecard#

Passes 4 of the 16 checks that could be worked out: strongest in valuation (2 of 4), weakest in profitability (0 of 4). Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation2 of 4
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median0.6×Price to book 0.6× against Healthcare's median of 3.1×.
    • ✓Price to sales below its peers' median0.5×Price to sales 0.5× against Healthcare's median of 3.7×.
    • –Free cash flow yield above 5%No free cash flow yield on file.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 4.92% (2026-11-20).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth1 of 3
    • ✓Revenue grew in the newest year107.6%Revenue up 107.6% in fiscal 2025.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-4.01 vs -13.77Diluted EPS -4.01 in fiscal 2025 against -13.77 the year before (report's currency).
    • ✗Net income higher than five years earlier-$33 M-$33 M in fiscal 2025 against -$23 M in 2020.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 4
    • ✗Profitable in the newest year-$33 MNet income -$33 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-378.1%-378.1% against Medical Equipment's median of -38.5% (8 companies).
    • ✗Return on equity above 15%-337.4%-337.4% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 4
    • ✓Short-term assets cover short-term liabilities3.8×Current ratio 3.80 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • ✗Operating income covers interest five times-8.2×Operating income -8.2 times interest in fiscal 2025.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-14.44Z-score -14.44 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year145.2%Diluted shares up 145.2% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Equipment, the 10-year Treasury yield of Nov 20, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Beyond Air, Inc.'s statements, beside the median of Medical Equipment.

Beyond Air, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-378.1%-38.5%
Net margin-432.9%-44.9%
Return on equity-337.4%-94.5%
Revenue growth107.6%15.6%
Free cash flow margin-249.5%-35.7%

6of 8on the Piotroski tests of financial strength

  • Net loss of $33 million, the 10th loss-making year in a row.
  • Free cash flow was negative: -$19 million.
  • The share count rose 145.2% in the year.
  • Operating income covers the interest bill only -8.2 times.

Beyond Air, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Beyond Air, Inc.: statements by fiscal year
PeriodTrendFY 2025to Mar 31, 2026FY 2024to Mar 31, 2025FY 2023to Mar 31, 2024FY 2022to Mar 31, 2023FY 2021to Mar 31, 2022FY 2020to Mar 31, 2021FY 2019to Mar 31, 2020FY 2018to Mar 31, 2019FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue7.73.71.2——0.9r1.47.7——
Cost of revenue7.45.42.50.6——————
Gross profit0.3−1.7−1.3−0.6——————
Research and development101724171213r113.94.4r0.7
Selling, general and administrative192637———————
General and administrative——37351810r8.9r6.96.6r1.0r
Operating expenses2943625241————0.1
Operating income−29−45−63−52−41−22r−18−3.1−11r−2.3r
Interest and finance income0.30.71.7———————
Interest expense and finance costs3.53.02.90.00.80.6r0.00.00.00.0
Net interest income————————−7.0−1.4
Other non-operating income (expense)−5.3−3.9−1.3−7.3−3.4−0.7r−2.0−3.5−7.0r−1.4
Income before tax−34−48−64−59−44−23r−20−6.6−18−3.7
Income tax——————−0.2r——0.0
Net income including minority interests−34−48−64−59−44−23————
Minority interests' share of net income−1.1−1.9−4.1−3.6−0.9—————
Net income attributable to shareholders−33−47−60−56−43−23r−20−6.6−18r−3.7r
Earnings per share, basic-4.01-13.77r-1.82-1.86-1.68-1.27-1.78-0.77-3.01-2.69r
Earnings per share, diluted-4.01-13.77r-1.82-1.86—-1.27-1.78-0.77-3.01-2.69r
Shares, weighted average (basic)8.33.4r333026r18,005—8.56.0—
Shares, weighted average (diluted)8.33.4r3330—18128.56.01.4r
Balance sheet
Cash and cash equivalents6.74.711298035r201.31.2r0.0r
Short-term investments4.92.32317———6.50.6—
Receivables1.10.70.30.40.30.4————
Inventory1.42.42.11.10.4—————
Other current assets0.20.2r6.84.4r2.0r1.5r1.10.80.00.0
Current assets251644599337r27r8.71.90.1r
Property, plant and equipment8.2119.45.02.00.9r0.20.20.30.1
Right-of-use (leased) assets1.21.72.12.52.21.9r0.2r———
Other intangible assets1.01.21.41.61.80.3r————
Non-current assets————————0.30.2
Total assets353057699941r279.42.20.2r
Accounts payable2.42.01.92.01.11.3r2.31.20.70.0
Debt due within a year—————————0.0
Current liabilities6.55.01220113.8r4.95.41.42.0r
Lease liabilities (non-current)1.01.51.92.32.11.8r0.1———
Non-current liabilities—————————2.9
Total liabilities291630272110r9.35.4r114.9r
Retained earnings−320−286−240−179−124−80r−58−38−32−14r
Shareholders' equity6.11425387330r18r4.0−8.4r−4.7r
Minority interests0.10.82.14.15.5—————
Total equity6.2142742783018——−4.7
Total liabilities and equity353057699941r279.42.20.2r
Shares outstanding0.6r4.1r463130r22168.76.12.2r
Cash-flow statement
Depreciation and amortization3.13.01.80.6r0.30.2r0.1r0.10.0—
Share-based compensation5.39.121207.84.9r3.62.44.4r0.4
Cash from operating activities−18−38−56−33−23−20r−151.3−7.1r−0.7r
Capital expenditure−1.0−5.9−5.7−3.9−1.4−0.9r−0.0−0.1−0.2—
Cash from investing activities−3.715−12−21−1.5−0.9r4.4−1.8−1.1r0.0
Shares issued4.519——25——0.8——
Shares bought back————————−0.0—
Cash from financing activities2917432.77930r351.19.5r0.6r
Change in cash7.5−6.7−25−51559.8r240.61.2r−0.1r
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Where Beyond Air, Inc. operates: 6 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 10 subsidiaries on file.

Beyond Air, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office2 subsidiaries—
🇮🇱 Israel3 subsidiaries—
🇮🇪 Ireland2 subsidiaries—
🇦🇺 Australia1 subsidiary—
🇧🇲 Bermuda1 subsidiary—
🇨🇾 Cyprus1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Beyond Air, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2026
$758 K
Robert Scott Goodman
Other top executives, average
$377 K
the CEO earned 2× this
$100 invested is now
$1
Beyond Air, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2026Robert Scott Goodman$758 K−$1.3 M$377 K$1
2025Robert Scott Goodman$821 K−$787 K$435 K$4
2024Robert Scott Goodman$1.7 M−$4.1 M$875 K$26

Source: SEC proxy statement (Form DEF 14A) · as of Mar 31, 2026

Events at Beyond Air, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Delisting noticeFiling

Delisting notice 1 · Directors and officers 7 · Material agreement 7 · New debt 1 · Unregistered share sale 4 · Shareholder rights changed 2 · Bylaws or fiscal year changed 3 · Shareholder vote 3 · Results announced 7

Beyond Air, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Directors and officersMaterial agreement8-K
Results announced8-K
Material agreementUnregistered share sale8-K
Shareholder rights changedBylaws or fiscal year changed8-K
Bylaws or fiscal year changedResults announced8-K
Shareholder vote8-K
Delisting notice8-K
Directors and officersMaterial agreement8-K
Results announced8-K
Shareholder vote8-K
Material agreementUnregistered share sale8-K
Directors and officersMaterial agreement8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Directors and officersMaterial agreementNew debtUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Results announced8-K
Shareholder rights changedBylaws or fiscal year changed8-K
Shareholder vote8-K
Directors and officersResults announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Oct 8, 2026

Acquisitions and funding#

1 private funding rounds before listing

Private share sales · funding history

Private share sales of Beyond Air, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2024$21 MPrivate placement after listing$10 to $50 million15equity, optionsSEC
Jun 2023$1 MPrivate placement after listingUnder $2 million2equity, optionsSEC
Jun 2019$8 MPrivate placement after listing$2 to $10 million47equitySEC
Feb 2018$10 MNo. 1$2 to $10 million58optionsSEC
Jan 2017$37 MIssued in a merger or acquisition$10 to $50 million58equity, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

How Beyond Air, Inc. compares in Medical Equipment

  • Market cap$4 M · higher than 0% of 8
  • Revenue$8 M · higher than 11% of 19
  • Net margin-407.6% · higher than 0% of 17
  • Revenue growth107.6% · highest of 13
  • Price / sales0.5× · lower than 83% of 7
  • Price / book0.6× · lower than 83% of 7

Peer comparison · Medical Equipment

CompanyMarket capP/ENet marginRev. growth
Beyond Air, Inc.🇺🇸$4 M—-407.6%+107.6%
Avita Medical, Inc.🇺🇸$525 M—-42.6%+11.5%
Viemed Healthcare, Inc.🇺🇸$367 M23.5×5.0%+20.5%
Electromed, Inc.🇺🇸$341 M28.6×15.8%+15.3%
Profound Medical Corp.🇨🇦$240 M—-137.4%+50.8%
Streamex Corp.🇺🇸$52 M——+100.0%
TELA Bio, Inc.🇺🇸$52 M—-53.6%+15.8%
IRIDEX Corporation🇺🇸$12 M—-6.9%+8.2%
Varian Medical Systems🇺🇸$16.3 B—8.5%-1.8%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending March-2026
Balance sheet:
As of March-2026
Employees:
As of March 31, 2026
Profile updated:
Nov 21, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Beyond Air, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Beyond Air, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Beyond Air, Inc.? Suggest a correction